nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACG 2024
|
Gomersall, Bethany |
|
|
10 |
1 |
p. 21 |
artikel |
2 |
Action on ultra-processed foods needs robust evidence
|
The Lancet Gastroenterology & Hepatology, |
|
|
10 |
1 |
p. 1 |
artikel |
3 |
Correction to Lancet Gastroenterol Hepatol 2024; 9: 774–75
|
|
|
|
10 |
1 |
p. e1 |
artikel |
4 |
Correction to Lancet Gastroenterol Hepatol 2024; 9: 718–33
|
|
|
|
10 |
1 |
p. e1 |
artikel |
5 |
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
|
Lindvig, Katrine P |
|
|
10 |
1 |
p. 55-67 |
artikel |
6 |
Eligibility for antiviral therapy in Senegal according to 2024 WHO hepatitis B guidelines
|
Wembulua, Bruce Shinga |
|
|
10 |
1 |
p. 19-20 |
artikel |
7 |
Gut Reaction
|
Trethewey, Fio |
|
|
10 |
1 |
p. 25 |
artikel |
8 |
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis
|
Coman, Diana |
|
|
10 |
1 |
p. 17-18 |
artikel |
9 |
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis
|
Hoffert, Yannick |
|
|
10 |
1 |
p. 18-19 |
artikel |
10 |
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis – Authors’ reply
|
Li Wai Suen, Christopher F D |
|
|
10 |
1 |
p. 19 |
artikel |
11 |
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
|
Gries, Jacob J |
|
|
10 |
1 |
p. 82-94 |
artikel |
12 |
It is time for World Hepatitis Testing Week
|
Halford, Rachel |
|
|
10 |
1 |
p. 11-13 |
artikel |
13 |
Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial
|
Jiang, Weizhong |
|
|
10 |
1 |
p. 34-43 |
artikel |
14 |
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease
|
Yadav, Abhishek |
|
|
10 |
1 |
p. 14 |
artikel |
15 |
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease
|
Duan, Ming |
|
|
10 |
1 |
p. 14-15 |
artikel |
16 |
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease
|
Kelm, Matthias |
|
|
10 |
1 |
p. 15-16 |
artikel |
17 |
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease
|
Coffey, J Calvin |
|
|
10 |
1 |
p. 15 |
artikel |
18 |
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease – Authors’ reply
|
van der Does de Willebois, Eline M L |
|
|
10 |
1 |
p. 16-17 |
artikel |
19 |
Oncological safety of laparoscopic surgery for low rectal cancer
|
Cho, Hye Jung |
|
|
10 |
1 |
p. 4-5 |
artikel |
20 |
Primary care diagnostic pathways for lower gastrointestinal symptoms
|
Din, Shahida |
|
|
10 |
1 |
p. 9-11 |
artikel |
21 |
Research in Brief
|
Baker, Holly |
|
|
10 |
1 |
p. 23 |
artikel |
22 |
Retraction—Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis
|
The Editors of The Lancet Gastroenterology & Hepatology, |
|
|
10 |
1 |
p. 13 |
artikel |
23 |
Retraction—What is normal and abnormal in lactose digestion?
|
The Editors of The Lancet Gastroenterology & Hepatology, |
|
|
10 |
1 |
p. 13 |
artikel |
24 |
Rome Foundation and international neurogastroenterology and motility societies’ consensus on idiopathic gastroparesis
|
Schol, Jolien |
|
|
10 |
1 |
p. 68-81 |
artikel |
25 |
Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
|
Daveson, A James M |
|
|
10 |
1 |
p. 44-54 |
artikel |
26 |
Shitbag: the story of a diagnosis
|
McQuillan, Cahal |
|
|
10 |
1 |
p. 24 |
artikel |
27 |
The Liver Meeting 2024
|
Brierley, Rob |
|
|
10 |
1 |
p. 22 |
artikel |
28 |
The promise of automated liver disease risk stratification in primary care
|
Åberg, Fredrik |
|
|
10 |
1 |
p. 5-7 |
artikel |
29 |
Unifying the approach to tackling inequalities in liver health: learning from working with underserved populations
|
Glyn-Owen, Kate |
|
|
10 |
1 |
p. 7-9 |
artikel |
30 |
Vedolizumab prophylaxis against postoperative Crohn's disease recurrence
|
Mulligan, Robert J |
|
|
10 |
1 |
p. 2-3 |
artikel |
31 |
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
|
D'Haens, Geert |
|
|
10 |
1 |
p. 26-33 |
artikel |